Journal of the American Academy of Dermatology

Oncology & Cancer

Another foe for the U.S. military: skin cancer

(HealthDay)—For U.S. military personnel, deployment carries many dangers. And besides the well-known threats they face, these men and women are also at a higher-than-average risk for skin cancer, including potentially deadly ...

Diseases, Conditions, Syndromes

Sustained use of oxymetazoline cream efficacious for rosacea

(HealthDay)—Oxymetazoline is safe and effective for the treatment of moderate-to-severe persistent erythema of rosacea, according to a study published in the June issue of the Journal of the American Academy of Dermatology.

Diseases, Conditions, Syndromes

Serlopitant found to be safe, effective for chronic pruritus

(HealthDay)—Serlopitant has potential as a therapy for the treatment of chronic pruritus, according to a study published in the May issue of the Journal of the American Academy of Dermatology.

Oncology & Cancer

Hydrochlorothiazide tied to non-melanoma skin cancer risk

(HealthDay)—Use of the diuretic hydrochlorothiazide is associated with a substantially increased risk of non-melanoma skin cancer, according to a study published in the April issue of the Journal of the American Academy ...

Oncology & Cancer

Guidelines of care developed for skin cancer management

(HealthDay)—Guidelines of care have been developed for the management of basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC), according to two reports published online Jan. 10 in the Journal of the American ...

Oncology & Cancer

Hydrochlorothiazide may up basal, squamous cell cancer risk

(HealthDay)—Hydrochlorothiazide use is associated with an increased risk of non-melanoma skin cancer (NMSC), with evidence of a dose-response relationship, according to a study published online Dec. 3 in the Journal of ...

page 9 from 25